Format

Send to

Choose Destination
Hepatogastroenterology. 2011 Mar-Apr;58(106):558-64.

Transcatheter arterial chemoembolization enhances expression of Nm23-H1 and TIMP-2 in the tumor tissue of patients with hepatocellular carcinoma.

Author information

1
Department of Interventional Radiology, Yueyang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China. luwei6702@126.com

Abstract

BACKGROUND/AIMS:

To investigate the effects of transcatheter arterial chemoembolization (TACE) on expression of nm23-H1 and TIMP-2 in the tumor tissue and prognosis of patients with hepatocellular carcinoma (HCC).

METHODOLOGY:

Seventy-two patients with resectable HCC were randomized into two equal groups with 36 patients in each: TACE before surgical resection of HCC (Group A) and direct surgical resection of HCC (Group B). All samples were subjected to pathological examination and immunohistochemical staining using nm23-H1 and TIMP-2 antibodies. Expression level and distribution of nm23-H1 and TIMP-2 in tumor and adjacent tissue were assessed. Extrahepatic metastasis and survival time of patients in both groups were evaluated through 36 months follow-up.

RESULTS:

Immunohistochemical analysis showed that the tumor tissues from patients in Group A had a higher positive expression of nm23-H1 than Group B (chi2=15.52, p<0.01). Group A also showed a higher positive expression of TIMP-2 than Group B (chi2=9.00, p<0.05). Patients in Group A had a longer mean survival time (36 vs. 28 months in Groups A and B, respectively) and higher survival rate (chi2=5.734, p=0.017).

CONCLUSIONS:

Preoperative TACE enhances the expression of metastasis suppressors nm23-H1 and TIMP-2, and may potentially inhibit metastasis of HCC and increase the survival time of patients with the resectable HCC.

PMID:
21661431
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center